Are you at least 21 years old?
You must be at least 21 to see this content, you will be redirected to google
Are you at least 21 years old?
You must be at least 21 to see this content, you will be redirected to google
A
• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)
• attention-deficit-hyperactivity-disorder-adhd (5)
B
C
D
• d9-tetrahydrocannabinol-thc (4)
• d9-tetrahydrocannabinolic-acid-thca (1)
E
• endocannabinoid-system-ecs (45)
F
G
• gastrointestinal-disease (6)
H
I
K
L
M
N
• national-institute-on-drug-abuse-nida (1)
• neuro-protective-and-neuro-generative (7)
P
S
T
• traumatic-brain-injury-tbi (1)
• View All (505)Benefits and adverse effects of cannabis use among adults with persistent pain (2018)
Increasingly, states are legalizing cannabis for recreational use. Improved accessibility can allow adults with pain to use cannabis more liberally. The purpose of this study was to examine the perceived effects of cannabis in adults who have been prescribed opioids for persistent pain. View study
Benefits and Harms of Cannabis in Chronic Pain or Post-traumatic Stress Disorder: A Systematic Review [Internet] (2017)
Recent studies indicate that between 45% and 80% of people who seek cannabis for medical purposes do so to control pain, which suggests its therapeutic potential in patients with chronic pain. View study
Canabimimetic plants: are they new cannabinoidergic modulators. (2019)
The objective of this review was to provide critical and complete assessment of the botanical, chemical and therapeutic aspects of cannabimimetic plants to evaluate their spread in the world and medicinal potentiality. View study
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines [Internet] (2016)
The objective of this research is to review the available published literature related to the oral spray THC: CBD for the treatment of chronic neuropathic or neuropathic pain in adults. Studies have been conducted on the therapeutic use of various synthetic cannabinoid products for the symptomatic relief of chronic pain. View study
Cannabinoid Delivery Systems for Pain and Inflammation Treatment. (2018)
This review aimed to explore the most recent developments, from preclinical to advanced clinical trials, in the field of cannabinoid administration, and focuses particularly on the treatment of pain and inflammation. Future probable directions are also considered and reported. View study
Cannabinoids for fibromyalgia (2016)
Fibromyalgia is a clinically well defined chronic condition of unknown etiology characterized by chronic widespread pain that often coexists with sleep and fatigue problems that affect approximately 2% of the general population. The present review focused on evaluating the efficacy, tolerability and safety of cannabinoids for the symptoms of fibromyalgia in adults. It could be concluded that no convincing, impartial and high quality evidence was found to suggest that nabilone is valuable in the treatment of people with fibromyalgia. The tolerability of nabilone was low in people with fibromyalgia. View study
Cannabinoids for treatment of chronic non-cancer pain: a systematic review of randomized trials (2011)
Cannabinoids are safe and more effective for the treatment of neuropathic pain with preliminary evidence of efficacy in fibromyalgia and rheumatoid arthritis without serious adverse effects. View study
Cannabis products for adults with chronic neuropathic pain (2018)
Cannabis products for people with fibromyalgia ()
Cannabis-based medicines for chronic neuropathic pain in adults. (2018)
Cannabis has been used for millennia to reduce pain. Herbal cannabis is currently strongly promoted by some patients and their advocates to treat any type of chronic pain.The present review aimed to evaluate the efficacy, tolerability and safety of cannabis-based medicines (herbal, derived of plants, synthetic) compared to conventional medications or placebo for conditions with chronic neuropathic pain in adults. View study
Gabapentin for Adults with Neuropathic Pain: A Review of the Clinical Evidence and Guidelines [Internet] (2014)
The purpose of this review is to investigate the clinical evidence on the efficacy and safety of the use of gabapentin in adults with neuropathic pain. In this investigation, it could be concluded that there is little evidence on the abuse and misuse of pregabalin, but existing data suggest that some populations with a history of substance abuse may be at increased risk of pregabalin abuse. View study
Gender differences in associations between pain-related anxiety and alcohol use among adults with chronic pain. (2019)
It has been shown that pain motivates the need and consumption of alcohol, and drinking to cope with pain predicts escalations in alcohol consumption over time. This research seeks to perform the first test of cross-sectional associations between anxiety related to pain, sex and alcohol consumption. View study